Amir Hossein Faraji

Amir Hossein Faraji

Auto-generated profile, based on publicly available information

Amir Hossein Faraji

Department of Neurosurgery, Houston Methodist, Houston, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Interdisciplinary Neurosurgery
Verified
Journal Article
Open access
SJSaad Javeed
Saad Javeed
AFAmir H. Faraji
Amir H. Faraji
CDChristopher Dy
Christopher Dy
WRWilson Z. Ray
Wilson Z. Ray
MMMatthew R. MacEwan
Matthew R. MacEwan

12 May 2024 in World Neurosurgery
Verified
Journal Article
Closed access
KTKhaled Taghlabi
Khaled Taghlabi
AQAhmad A. Quaddoura
Ahmad A. Quaddoura
ANArsalan Nisar
Arsalan Nisar
PGParas Gupta
Paras Gupta
LBLokeshwar S. Bhenderu
Lokeshwar S. Bhenderu
AFAmir H. Faraji
Amir H. Faraji

1 September 2024 in Neurosurgical Focus
Verified
Journal Article
Open access
PDF file
AMAli Mortezaei
Ali Mortezaei
MEMuhammed Amir Essibayi
Muhammed Amir Essibayi
MEMohammad Mirahmadi Eraghi
Mohammad Mirahmadi Eraghi
MAMohammadreza Alizadeh
Mohammadreza Alizadeh
KTKhaled M. Taghlabi
Khaled M. Taghlabi
AFAmir H. Faraji
Amir H. Faraji
OBJECTIVE: Magnetic resonance–guided focused ultrasound (MRgFUS) is an emerging treatment for medication-refractory essential tremor (ET). The objective of this study was to evaluate long-term (up to 5 years) safety and efficacy of unilateral MRgFUS in the treatment of ET. METHODS: The authors performed a systematic search through 4 databases to find relevant clinical studies. Binary outcomes were analyzed and reported as odds ratios and 95% confidence intervals, while continuous outcomes were analyzed and reported as standardized mean differences (SMDs) and 95% confidence intervals. Furthermore, a univariable meta-regression was performed to evaluate the association between various covariates and the outcomes including the mean difference in the Clinical Rating Scale for Tremor (CRST) score and hand tremor scores. Sensitivity analysis was performed to address any heterogeneity. RESULTS: A total of 43 studies comprising 1818 patients with ET who underwent MRgFUS were identified. Of the 1539 patients with data on sex, 1095 (71.2%) were male. The mean follow-up duration ranged from 3 months to 8.4 years among the studies. The mean total CRST score significantly decreased at 3, 6, and 12 months post-MRgFUS (SMD −4.5, p = 0.0069; SMD −4.9, p = 0.0045; and SMD −2.95, p = 0.0039, respectively). The mean hand tremor scores significantly mitigated at 3, 6, 12, 24, and 36 months post-MRgFUS (SMD −3.99, p = 0.05; SMD −4.5, p = 0.05; SMD −1.99, p < 0.0001; SMD − 2.07, p = 0.0002; and SMD −2.1, p < 0.0001, respectively). Furthermore, the mean Quality of Life in Essential Tremor Questionnaire scores were improved at 3 months (SMD −2.8, p = 0.0025), 6 months (SMD −4.1, p = 0.04), 12 months (SMD −1.57, p = 0.0004), 2 years (SMD −1.64, p = 0.0003), and 3 years (SMD −1.14, p = 0.08). Our meta-regression findings showed that sex (p = 0.03), unlike age, handedness, symptom duration, and peak energy levels at 3 months, was associated with a significantly higher mean difference in tremor severity. CONCLUSIONS: This meta-analysis provides strong evidence supporting the efficacy and safety of unilateral MRgFUS for the treatment of ET in terms of tremor severity and quality of life with acceptable adverse events.

1 July 2021 in World Neurosurgery
Verified
Journal Article
Closed access
AFAmir H. Faraji
Amir H. Faraji
SRSibi Rajendran
Sibi Rajendran
AJAndrea S. Jaquins-Gerstl
Andrea S. Jaquins-Gerstl
HHHunter J. Hayes
Hunter J. Hayes
RRR. Mark Richardson
R. Mark Richardson

1 August 2019 in World Neurosurgery
Verified
Journal Article
Closed access
BZBenjamin M. Zussman
Benjamin M. Zussman
EGEzequiel Goldschmidt
Ezequiel Goldschmidt
AFAmir H. Faraji
Amir H. Faraji
DSDavid J. Salvetti
David J. Salvetti
BJBrian T. Jankowitz
Brian T. Jankowitz

1 January 2019 in Journal of Neuroscience Methods
Verified
Journal Article
Open access
AFAmir H. Faraji
Amir H. Faraji
AJAndrea S. Jaquins-Gerstl
Andrea S. Jaquins-Gerstl
AVAlec C. Valenta
Alec C. Valenta
SWStephen G. Weber
Stephen G. Weber
Delivering solutes to a particular region of the brain is currently achieved by iontophoresis for very small volumes and by diffusion from a microdialysis probe for larger volumes. There is a need to deliver solutes to particular areas with more control than is possible with existing methods. Electrokinetic infusions of solutes were performed into hydrogels and organotypic hippocampal slice cultures. Application of an electrical current creates electroosmotic flow and electrophoresis of a dicationic fluorescent solute through organotypic hippocampal tissue cultures or larger hydrogels. Transport was recorded with fluorescence microscopy imaging in real-time. Electrokinetic transport in brain tissue slice cultures and hydrogels occurs along an electrical current path and allows for anisotropic delivery over distances from several hundred micrometers to millimeters. Directional transport may be controlled by altering the current path. The applied electrical current linearly affects the measured solute fluorescence in our model system following infusions. Localized drug delivery involves iontophoresis, with diffusion primarily occurring beyond infusion capillaries under current protocols. Pressure-driven infusions for intraparenchymal targets have also been conducted. Superfusion across a tissue surface provides modest penetration, however is unable to impact deeper targets. In general, control over intraparenchymal drug delivery has been difficult to achieve. Electrokinetic transport provides an alternative to deliver solutes along an electrical current path in tissue. Electrokinetic transport may be applied to living systems for molecular transport. It may be used to improve upon the control of solute delivery over that of pressure-driven transport.